HMGB1 in exosomes derived from gastric cancer cells induces M2‐like macrophage polarization by inhibiting the NF‐κB signaling pathway
Cell Biology International · 2024-03 · 48 (3) · 334-346
DOI: 10.1002/cbin.12110 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Biology International, online erschienen am 17.12.2023. Verfasst von Ke Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiotherapy, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: Exosomes, HMGB1 Protein, MicroRNAs, Stomach Neoplasms. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: Hunan Cancer Hospital Climb Plan, Hunan Provincial Natural Science Foundation of China.
Abstract (Originalsprache)
Gastric cancer (GC) seriously threatens human health. High mobility group protein B1 (HMGB1) and M2‐like macrophages are closely associated with core events about human cancers, such as invasion, and metastasis, and cancer microenvironment. This study mainly determined the regulatory effect of HMGB1 in GC cell‐derived exosomes on M2‐like macrophage polarization as well as the underlying mechanism. HMGB1 was found to be highly expressed in gastric tissue specimens, which might lead to the poor prognosis of GC. High levels of HMGB1 were also observed in the plasma of GC patients, indicating the possibility that it regulates the immune microenvironment via exosomes. Further study revealed and confirmed the regulatory effect of exosomes derived from GC cells with high HMGB1 level on inducing M2‐like macrophage polarization. Mechanistically, by interacting with the transcription factor POU2F1, exosomal HMGB1 inhibited the transcriptional activity of p50, resulting in the inactivation of NF‐κB signaling pathway and thereby inducing M2‐like macrophage polarization. Moreover, instead of promoting the proliferation of GC cells, exosomes with high HMGB1 levels induced M2‐like macrophage polarization and promoted GC progression. This study reveals a novel mechanism by which HMGB1 promotes GC progression, which may provide new insights for improving the efficacy of cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiotherapy, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
- Department of Radiotherapy, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Changsha, Hunan, China.
- Key Laboratory of Translational Radiation Oncology, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China.
- Department of Gastrointestinal Surgery, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China.
- Department of Hepatobiliary and Intestinal Surgery, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China.
Förderung
- Hunan Cancer Hospital Climb Plan
- Hunan Provincial Natural Science Foundation of China
Zitieren
APA
Liu, K., Wang, H., Zhou, J., Zhu, S., Ma, M., Xiao, H., & Ding, Y. (2024). HMGB1 in exosomes derived from gastric cancer cells induces M2‐like macrophage polarization by inhibiting the NF‐κB signaling pathway. Cell Biology International, 48(3), 334-346. https://doi.org/10.1002/cbin.12110
Vancouver
Liu K, Wang H, Zhou J, Zhu S, Ma M, Xiao H, et al. HMGB1 in exosomes derived from gastric cancer cells induces M2‐like macrophage polarization by inhibiting the NF‐κB signaling pathway. Cell Biology International. 2024;48(3):334-346. doi:10.1002/cbin.12110
BibTeX
@article{Liu2024,
author = {Liu, Ke and Wang, Hui and Zhou, Jumei and Zhu, Suyu and Ma, Min and Xiao, Hua and Ding, Yi},
title = {HMGB1 in exosomes derived from gastric cancer cells induces M2‐like macrophage polarization by inhibiting the NF‐κB signaling pathway},
journal = {Cell Biology International},
year = {2024},
volume = {48},
number = {3},
pages = {334--346},
doi = {10.1002/cbin.12110}
}
EUVIMED